127 related articles for article (PubMed ID: 15909172)
1. Acute putaminal necrosis and white matter demyelination in a child with subnormal copper metabolism in Wilson disease: MR imaging and spectroscopic findings.
Juan CJ; Chen CY; Liu YJ; Chung HW; Chin SC; Hsueh CJ; Chu H; Zimmerman RA
Neuroradiology; 2005 Jun; 47(6):401-5. PubMed ID: 15909172
[TBL] [Abstract][Full Text] [Related]
2. Clinical correlates of cerebral water diffusion in Wilson disease.
Favrole P; Chabriat H; Guichard JP; Woimant F
Neurology; 2006 Feb; 66(3):384-9. PubMed ID: 16476937
[TBL] [Abstract][Full Text] [Related]
3. Role of diffusion weighted magnetic resonance imaging and spectroscopy in the diagnosis and follow-up of hepatolenticular degeneration.
Xue P; Liu Y; Ma XH; Chen Y; Zhang SJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):497-502. PubMed ID: 23134827
[TBL] [Abstract][Full Text] [Related]
4. Kayser-Fleischer ring with keratoconus: a coincidence? A case report.
Hu P; Lin L; Wu Z; Jin X; Ni H
BMC Ophthalmol; 2020 May; 20(1):190. PubMed ID: 32404122
[TBL] [Abstract][Full Text] [Related]
5. Post-hypoxic early selective putaminal necrosis followed by delayed extensive sub-cortical demyelination.
Sharma VK; Tan JH
Brain Inj; 2007 Oct; 21(11):1199-202. PubMed ID: 17882629
[TBL] [Abstract][Full Text] [Related]
6. A study of MRI changes in Wilson disease and its correlation with clinical features and outcome.
Ranjan A; Kalita J; Kumar S; Bhoi SK; Misra UK
Clin Neurol Neurosurg; 2015 Nov; 138():31-6. PubMed ID: 26278999
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics of patients with delayed hepatolenticular degeneration].
Zhou XX; Qin HL; He RX; Chen DB; Wu C; Feng L; Li XH; Liang XL
Zhonghua Nei Ke Za Zhi; 2019 Jul; 58(7):501-507. PubMed ID: 31269566
[No Abstract] [Full Text] [Related]
8. Is it possible to diagnose Wilson disease with a piece of skin?
Eşrefoğlu M; Gül M; Seyhan M; Selimoğlu MA
Ultrastruct Pathol; 2009 Dec; 33(6):265-8. PubMed ID: 19929173
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance proton spectroscopy of the brain in Wilson's disease.
Kraft E; Trenkwalder C; Then Bergh F; Auer DP
J Neurol; 1999 Aug; 246(8):693-9. PubMed ID: 10460447
[TBL] [Abstract][Full Text] [Related]
10. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
11. Detection of Kayser-Fleischer ring using Scheimpflug imaging.
Telinius N; Ott P; Hjortdal J
Acta Ophthalmol; 2017 May; 95(3):e248-e249. PubMed ID: 27683232
[No Abstract] [Full Text] [Related]
12. Evaluation of Kayser-Fleischer ring in Wilson disease by anterior segment optical coherence tomography.
Sridhar MS; Rangaraju A; Anbarasu K; Reddy SP; Daga S; Jayalakshmi S; Shaik B
Indian J Ophthalmol; 2017 May; 65(5):354-357. PubMed ID: 28573989
[TBL] [Abstract][Full Text] [Related]
13. Osmotic demyelination syndrome diagnosed radiologically during Wilson's disease investigation.
Júnior SFA; Ventura N; Marchiori E
Eur J Neurol; 2021 Feb; 28(2):726-728. PubMed ID: 33022802
[TBL] [Abstract][Full Text] [Related]
14. Diffusion MR imaging changes associated with Wilson disease.
Sener RN
AJNR Am J Neuroradiol; 2003 May; 24(5):965-7. PubMed ID: 12748103
[TBL] [Abstract][Full Text] [Related]
15. Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study.
Dusek P; Bahn E; Litwin T; Jabłonka-Salach K; Łuciuk A; Huelnhagen T; Madai VI; Dieringer MA; Bulska E; Knauth M; Niendorf T; Sobesky J; Paul F; Schneider SA; Czlonkowska A; Brück W; Wegner C; Wuerfel J
Neuropathol Appl Neurobiol; 2017 Oct; 43(6):514-532. PubMed ID: 27543917
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte metabolism and antioxidant status of patients with Wilson disease with hemolytic anemia.
Attri S; Sharma N; Jahagirdar S; Thapa BR; Prasad R
Pediatr Res; 2006 Apr; 59(4 Pt 1):593-7. PubMed ID: 16549536
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of neurological Wilson's disease without Kayser-Fleischer ring.
Youn J; Kim JS; Kim HT; Lee JY; Lee PH; Ki CS; Cho JW
J Neurol Sci; 2012 Dec; 323(1-2):183-6. PubMed ID: 23043908
[TBL] [Abstract][Full Text] [Related]
18. Effect of liver transplantation on neurological manifestations in Wilson disease.
Stracciari A; Tempestini A; Borghi A; Guarino M
Arch Neurol; 2000 Mar; 57(3):384-6. PubMed ID: 10714666
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between portal-systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H-1 MR spectroscopy.
Van Den Heuvel AG; Van der Grond J; Van Rooij LG; Van Wassenaer-van Hall HN; Hoogenraad TU; Mali WP
Radiology; 1997 May; 203(2):539-43. PubMed ID: 9114118
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin a nephropathy as the first clinical presentation of Wilson disease: a case report and literature review.
Zhang YZ; Jian G; He P; Yu R; Tian M; Wu Y; Zhang BR
BMC Gastroenterol; 2021 Oct; 21(1):384. PubMed ID: 34666712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
